MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

Glioblastoma is the most aggressive brain tumor in adults with a median survival below 12 months in population-based studies. The main reason for tumor recurrence and progression is constitutive or acquired resistance to the standard of care of surgical resection followed by radiotherapy with concom...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Stojcheva, Nina, Schechtmann, Gennadi, Sass, Steffen, Roth, Patrick, Florea, Ana-Maria, Stefanski, Anja, Stühler, Kai, Wolter, Marietta, Müller, Nikola S., Theis, Fabian J., Weller, Michael, Reifenberger, Guido, Happold, Caroline
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914333/
https://ncbi.nlm.nih.gov/pubmed/26887050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7346
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi